TY - JOUR
T1 - Newer asthma therapies
AU - Smith, L. J.
PY - 1999/3/16
Y1 - 1999/3/16
N2 - In patients with asthma, the overall response rate to the gold standard treatment, corticosteroids, may be as low as 70%. Clearly, there is a need to identify treatments that are effective when corticosteroids are not. Malmstrom and colleagues' study in this issue contributes to other studies that have increased our understanding of the beneficial effects and safety of leukotriene receptor antagonists.
AB - In patients with asthma, the overall response rate to the gold standard treatment, corticosteroids, may be as low as 70%. Clearly, there is a need to identify treatments that are effective when corticosteroids are not. Malmstrom and colleagues' study in this issue contributes to other studies that have increased our understanding of the beneficial effects and safety of leukotriene receptor antagonists.
UR - http://www.scopus.com/inward/record.url?scp=0033574196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033574196&partnerID=8YFLogxK
U2 - 10.7326/0003-4819-130-6-199903160-00018
DO - 10.7326/0003-4819-130-6-199903160-00018
M3 - Short survey
C2 - 10075622
AN - SCOPUS:0033574196
SN - 0003-4819
VL - 130
SP - 531
EP - 532
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 6
ER -